Kymera Therapeutics appoints Terence Rooney as CMO; Jared Gollob retires

Kymera Therapeutics, Inc.

Jared Gollob retired as CMO effective July 27, 2026; will remain as advisor through Dec 31, 2026.
Terence Rooney appointed CMO, previously SVP Portfolio & Asset Management Leader, Immunology at Johnson & Johnson.
Rooney also held senior immunology R&D roles at Eli Lilly and Roche; contributed to approvals of STELARA, TREMFYA, OLUMIANT.
Gollob's resignation is for personal reasons and not due to any disagreement with company policies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.